Tesei, A.; Cortesi, M.; Bedeschi, M.; Marino, N.; Rossino, G.; Listro, R.; Rossi, D.; Linciano, P.; Collina, S.
Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer. Molecules 2022, 27, 4327.
https://doi.org/10.3390/molecules27144327
AMA Style
Tesei A, Cortesi M, Bedeschi M, Marino N, Rossino G, Listro R, Rossi D, Linciano P, Collina S.
Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer. Molecules. 2022; 27(14):4327.
https://doi.org/10.3390/molecules27144327
Chicago/Turabian Style
Tesei, Anna, Michela Cortesi, Martina Bedeschi, Noemi Marino, Giacomo Rossino, Roberta Listro, Daniela Rossi, Pasquale Linciano, and Simona Collina.
2022. "Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer" Molecules 27, no. 14: 4327.
https://doi.org/10.3390/molecules27144327
APA Style
Tesei, A., Cortesi, M., Bedeschi, M., Marino, N., Rossino, G., Listro, R., Rossi, D., Linciano, P., & Collina, S.
(2022). Repurposing the Antiplatelet Agent Ticlopidine to Counteract the Acute Phase of ER Stress Condition: An Opportunity for Fighting Coronavirus Infections and Cancer. Molecules, 27(14), 4327.
https://doi.org/10.3390/molecules27144327
